T2 Biosystems Garners $15,000,000 Series C Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7f799d77-df7c-4c99-aaed-0cbe707d8c98&Preview=1 - Date
5/25/2010 - Company Name
T2 Biosystems - Mailing Address
286 Cardinal Medeiros Avenue Cambridge, MA 02141 - Company Description
T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital. Using this technology, we are developing a range of diagnostic products to impact a variety of health care settings; from centralized testing laboratories to point of care. - Website
http://www.t2biosystems.com - Transaction Type
Venture Equity - Transaction Amount
$15,000,000 - Transaction Round
Series C - Proceeds Purposes
Proceeds from the financing will be usedto accelerate the development and commercialization of T2 Biosystems’ next generation diagnosticplatform for use in the decentralized setting. - M&A Terms
- Venture Investor
Physic Ventures - Venture Investor
Arcus Ventures - Venture Investor
Polaris Venture Partners - Venture Investor
Flybridge Capital Partners - Venture Investor
WS Investment - Venture Investor
Flagship Ventures - Venture Investor
Partners HealthCare System
